Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y2UR
|
|||
| Former ID |
DNC013806
|
|||
| Drug Name |
Methylcarbamic Acid Biphenyl-3-yl Ester
|
|||
| Synonyms |
CHEMBL486290; Methylcarbamic Acid Biphenyl-3-yl Ester; SCHEMBL12133520; BDBM50270688
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H13NO2
|
|||
| Canonical SMILES |
CNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2
|
|||
| InChI |
1S/C14H13NO2/c1-15-14(16)17-13-9-5-8-12(10-13)11-6-3-2-4-7-11/h2-10H,1H3,(H,15,16)
|
|||
| InChIKey |
NYOGSYRWQAQOKA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.